Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 May 2000

Miettinen M, Sarlomo-Rikala M, Lasota J

Abstract excerpt

C-kit proto-oncogene product (KIT, CD117) is a tyrosine kinase growth factor receptor for stem cell factor. This receptor is important for the development and maintenance of hematopoietic stem cells, mast cells, germ cells, melanocytes, and interstitial cells of Cajal and is constitutively expres...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA, Neoplasm
Share to Endothelium, Vascular
Share to Fetus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemangiosarcoma

Share to Immunohistochemistry

Share to Proto-Oncogene Mas

Share to Proto-Oncogene Proteins c-kit

Share to Sarcoma, Kaposi

Source

Identifiers

PMID: 10824925
DOI: 10.1038/modpathol.3880093

Genes

KIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-10824925-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit.PMID 10824925Read ↗

KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation.Semantic proximity Read ↗

Clinicopathologic assessment of postradiation sarcomas: KIT as a potential treatment target.Semantic proximity Read ↗

Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma.Semantic proximity Read ↗

Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.Semantic proximity Read ↗

Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.Semantic proximity Read ↗

Contrasting effects of VEGF gene disruption in embryonic stem cell-derived versus oncogene-induced tumors.Semantic proximity Read ↗

Rare expression of KIT and absence of KIT mutations in high grade renal cell carcinoma.Semantic proximity Read ↗

Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT.Semantic proximity Read ↗

MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas.Semantic proximity Read ↗

KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma.Semantic proximity Read ↗

KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.